Alamar Biosciences, Inc. (NasdaqGS: ALMR)
Health Care · Life Sciences Tools & Services · US
$30.81
-2.99% today · +40.0% 1Y
Alamar Biosciences, Inc. (NasdaqGS: ALMR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.14B and employs 222 people.
Over the last twelve months the share price has gained 40.0%, trading between 18.85 and 39.61.
Tweenvest scores Alamar Biosciences, Inc. across four factors: quality 49/100, value 67/100. Its strongest factor is value.
ALMR price history
Key figures
- Market cap
- $2.14B
- Revenue (TTM)
- $114.05M
- P/E
- -43.11
- EPS
- -2.26
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $39.61
- 52-week low
- $18.85
- Avg volume (3M)
- —
- Shares outstanding
- 69.48M
- Employees
- 222
- Next earnings
- —
About Alamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
- ISIN
- US0109111056
- Founded
- 2018
- Listed since
- Apr 17, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Haoyuan Chemexpress Co., Ltd.SHSE: 688131 | $2.97B | CN¥93.00 | -2.66% |
| Oxford Nanopore Technologies plcLSE: ONT | $2.56B | £2.00 | +1.48% |
| InSilico Medicine Cayman TopCoSEHK: 3696 | $2.46B | HK$33.46 | -3.35% |
| HitGen Inc.SHSE: 688222 | $2.28B | CN¥37.99 | -7.00% |
| AddLife AB (publ)OM: ALIF B | $2.13B | Skr178.20 | +0.45% |
| GemPharmatech Co., Ltd.SHSE: 688046 | $1.99B | CN¥32.47 | -5.88% |
| Azenta, Inc.NasdaqGS: AZTA | $1.97B | $47.09 | -3.29% |
| OneSource Specialty Pharma LimitedNSEI: ONESOURCE | $1.94B | Rs1,580.80 | -1.98% |